In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Recommended for at-risk children: ATAGI recommends COVID-19 vaccination for children aged 6 months to <5 years with severe immunocompromise, disability, and those who have complex and/or multiple health conditions which increase the risk of severe COVID-19. This includes conditions listed in the ATAGI recommendations and similar conditions.
Not recommended for all children: ATAGI does not currently recommend vaccination for children aged 6 months to <5 years who are not in the risk categories for severe COVID-19.
Dosing and schedule: Paediatric formulation (25mcg) Moderna COVID-19 vaccine, 2 primary doses 8 weeks apart. Children with severe immunocompromise should receive a 3rd primary dose, 8 weeks after the 2nd dose.
Monkeypox (MPX)
Availability of vaccines
Two vaccines are/will be available in Australia for prevention of monkeypox:
ACAM2000™ (2nd generation) is only available from the National Medical Stockpile on a request basis for State and Territory governments
JYNNEOS® (3rd generation) have been secured in limited supplies by the Commonwealth and some States and Territories
NSW Health is working as quickly as possible to facilitate access to JYNNEOS® vaccines
Access to vaccines
Vaccines for the prevention of monkeypox virus is being managed by NSW Health. More information about MPX vaccination hubs and/or access to vaccines will become available soon. Check our CESPHN Alerts webpage for a consolidation of monkeypox information from key organisations (NSW Heath, Dept of Health, ACON, SHIL, and more)
Monkeypox resources
ATAGI has released guidance on the use of smallpox vaccine for protection against Monkeypox (MPX) virus infection.
The Department of Health and Aged Care has produced a collection of Monkeypox (MPX) resources for health professionals. The monkeypox situation in Australia is updated regularly on their website.
Infectious Disease Specialist (ID specialist) 8890 5555 – for any suspected monkeypox cases, GPs must immediately contact the ID specialist before taking any samples. The ID specialist will advise on the appropriate test and clinical management of the case.
Public Health Unit (PHU) 1300 066 055 – GPs must notify any suspected cases of monkeypox to the PHU to initiate a public health investigation, contact tracing and control measures. MPX has been added to the list of notifiable diseases under the Public Health Act 2010.
NSW Sexual Health Infolink (SHIL) 1800 451 624 – SHIL provides specialist clinical support and information to health professionals who are treating clients with sexual health issues, including monkeypox infections.
Monkeypox support – Key contacts for patients
NSW Sexual Health Infolink (SHIL) 1800 451 624 – SHIL provides sexual health information and referral services to community members, including monkeypox information and advice.
ACON9206 2000 – provides monkeypox information for LGBTQ+ communities in NSW. ACON is working with health authorities to facilitate vaccine access as quickly as possible, particularly for higher risk groups in LGBTQ+ communities.
New AIR code for smallpox vaccine
There have been 3 smallpox vaccines added to the list of AIR vaccine code formats that are able to be recorded on the Australian Immunisation Register. Smallpox vaccines given overseas can be recorded either using the specific vaccine code or the generic smallpox code.
ACAM2000
JYNNEOS
Generic smallpox
GP knowledge gaps with Zostavax use in the immunocompromised
New research has found notable knowledge gaps continue to exist among Australian general practitioners (GPs) regarding live attenuated zoster vaccination of immunocompromised people.
While the vaccine is safe, its use is contraindicated in severely immunocompromised people because the virus from the vaccine can cause serious disseminated infection. There have been three Zostavax-related deaths in immunocompromised people between 2017 and 2020 in Australia.
The research, led by NCIRS, used an online survey to assess the knowledge of GPs regarding Zostavax. GPs were asked to respond to five clinical scenarios testing their knowledge of Zostavax contraindications, and the proportion of correct answers ranged from 25% to 82% across all scenarios.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 25 JANUARY 2023 COVID-19 cases in the region The number of reported COVID cases in our region has decreased over the last week and there are declines in hospital presentations, and residential aged care facility outbreaks. Infection control and wearing masks (staff and patients) is still…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. One Door Mental Health CEO Kathi Boorman shared this: 1. What exercise did you do yesterday? Most mornings, I get up at around 5 am and exercise for 30 minutes on my exercise…
Australian Digital Health Agency (ADHA) digital health foundations webinars The meaningful use of digital health in Australia is underpinned by healthcare organisations connecting to the Healthcare Identifiers (HI) service. This four-part webinar series will provide managers of medical practices, community pharmacies and other healthcare organisations with an understanding of the…
Palliative Care Resource Pack for Primary Care CareSearch has just released the Primary Health Care Resource Pack containing: communication starters, forms for assessing deterioration, forms to assess carer needs, a checklist of PBS prescriber medicines that can be used in terminal care, a practical checklist to guide and support a…
Palliative Care Resources for GPs CareSearch has now released printable versions of the reference guides to help GPs navigate CareSearch resources. These guides will direct you to actionable, relevant, evidence-based CareSearch resources to assist you in providing palliative care, including to specific populations. You can either download or order for…
New care finder services to assist older people in central and eastern Sydney The Central and Eastern Sydney Primary Health Network (CESPHN) is establishing a care finder program on behalf of the Australian Government. This follows recommendations from the Royal Commission into Aged Care Quality and Safety, which called for…